131 related articles for article (PubMed ID: 35116946)
1. Knockdown of actin-like 8 inhibits cell proliferation by regulating FOXM1, STMN1, PLK1, and BIRC5 in lung adenocarcinoma A549 cells.
Ma S; Qiang G; Shao W; Liang C; Wang X; Liu D
Transl Cancer Res; 2019 Sep; 8(5):1975-1984. PubMed ID: 35116946
[TBL] [Abstract][Full Text] [Related]
2. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway.
Li Z; Zhang Y; Zhou Y; Wang F; Yin C; Ding L; Zhang S
Sci Rep; 2021 Dec; 11(1):23681. PubMed ID: 34880385
[TBL] [Abstract][Full Text] [Related]
4. Actin-like protein 8, a member of cancer/testis antigens, supports the aggressive development of oral squamous cell carcinoma cells via activating cell cycle signaling.
Wang L; Xing X; Tian H; Fan Q
Tissue Cell; 2022 Apr; 75():101708. PubMed ID: 35051678
[TBL] [Abstract][Full Text] [Related]
5. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
Li B; Zhu J; Meng L
Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
[TBL] [Abstract][Full Text] [Related]
6. Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway.
Fan S; Yan S; Yang Y; Shang J; Hao M
Onco Targets Ther; 2021; 14():2463-2473. PubMed ID: 33883901
[TBL] [Abstract][Full Text] [Related]
7. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549].
Zhou Q; Bai M; Su Y
Ai Zheng; 2005 Feb; 24(2):149-54. PubMed ID: 15694023
[TBL] [Abstract][Full Text] [Related]
8. DUS4L Silencing Suppresses Cell Proliferation and Promotes Apoptosis in Human Lung Adenocarcinoma Cell Line A549.
Li Z; Yin C; Li B; Yu QY; Mao WJ; Li J; Lin JP; Meng YQ; Feng HM; Jing T
Cancer Manag Res; 2020; 12():9905-9913. PubMed ID: 33116848
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin A knockdown decreases the proliferation and invasion of A549 lung adenocarcinoma cells.
Hu B; Zhu X; Lu J
Mol Med Rep; 2020 Jun; 21(6):2553-2559. PubMed ID: 32323791
[TBL] [Abstract][Full Text] [Related]
10. Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma.
Ni L; Sun P; Fan X; Li Z; Ren H; Li J
Front Pharmacol; 2021; 12():775514. PubMed ID: 35173608
[No Abstract] [Full Text] [Related]
11. The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating
Tang XY; Xiong YL; Shi AP; Sun Y; Han Q; Lv Y; Shi XG; Frattini M; Malhotra J; Zheng KF; Liu YJ; Jiang T; Ma N; Zhao JB
Transl Lung Cancer Res; 2022 Mar; 11(3):404-419. PubMed ID: 35399566
[TBL] [Abstract][Full Text] [Related]
12. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
[TBL] [Abstract][Full Text] [Related]
13. Effect of antisense RNA targeting polo-like kinase 1 on cell cycle and proliferation in A549 cells.
Zhou Q; Bai M; Su Y
Chin Med J (Engl); 2004 Nov; 117(11):1642-9. PubMed ID: 15569479
[TBL] [Abstract][Full Text] [Related]
14.
Chen F; Zhu XQ; Zheng J; Xu TT; Wu K; Ru CH
Math Biosci Eng; 2020 Jan; 17(3):2150-2163. PubMed ID: 32233528
[No Abstract] [Full Text] [Related]
15. Targetable vulnerability of deregulated FOXM1/PLK1 signaling axis in diffuse large B cell lymphoma.
Yu F; He H; Nastoupil LJ; Xu-Monette ZY; Pham K; Liang Y; Chen G; Fowler NH; Yin CC; Tan D; Yang Y; Hu S; Young KH; Pham LV; You MJ
Am J Cancer Res; 2022; 12(10):4666-4679. PubMed ID: 36381323
[TBL] [Abstract][Full Text] [Related]
16.
Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
Front Oncol; 2021; 11():754290. PubMed ID: 34745988
[TBL] [Abstract][Full Text] [Related]
17. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
Ni KW; Sun GZ
Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
[TBL] [Abstract][Full Text] [Related]
18. LINC00511 Knockdown Suppresses Resistance to Cisplatin in Lung Adenocarcinoma by Interacting with miR-182-3p and BIRC5.
Zhu Z; Shi Y; Gong X; Li J; Zhang M
Mol Biotechnol; 2022 Mar; 64(3):252-262. PubMed ID: 34595724
[TBL] [Abstract][Full Text] [Related]
19. MiR-509-3-5p causes aberrant mitosis and anti-proliferative effect by suppression of PLK1 in human lung cancer A549 cells.
Wang XH; Lu Y; Liang JJ; Cao JX; Jin YQ; An GS; Ni JH; Jia HT; Li SY
Biochem Biophys Res Commun; 2016 Sep; 478(2):676-82. PubMed ID: 27498003
[TBL] [Abstract][Full Text] [Related]
20. FOXM1 participates in PLK1-regulated cell cycle progression in renal cell cancer cells.
Zhang Z; Zhang G; Kong C
Oncol Lett; 2016 Apr; 11(4):2685-2691. PubMed ID: 27073539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
